Michael Drey

What is polypharmacy? A systematic review of definitions

Prevalence and associated factors of sarcopenia among elderly in Brazil: Findings from the SABE study

Caring for frail older people in the last phase of life – the general practitioners’ view

Frailty Consensus: A Call to Action

Sarcopenia: a chronic complication of type 2 diabetes mellitus

Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial

Use it or lose it to age: A review of bone and muscle communication

The frailty instrument of the survey of health, ageing and retirement in Europe (SHARE-FI) predicts mortality beyond age, comorbidities, disability, self-rated health, education and depression

Relationship between depression and frailty in older adults: A systematic review and meta-analysis

Frailty Assessment in the Cardiovascular Care of Older Adults

Malnutrition in elderly: Social and economic determinants

Sarcopenia

Frailty: implications for clinical practice and public health

Physical activity in older age: perspectives for healthy ageing and frailty

Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty

Muscle Quality in Aging: a Multi-Dimensional Approach to Muscle Functioning with Applications for Treatment

Walking Speed: The Functional Vital Sign

From muscle wasting to sarcopenia and myopenia: update 2012

Frailty and Multimorbidity: A Systematic Review and Meta-analysis

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Frailty prevalence and slow walking speed in persons age 65 and older: implications for primary care

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people

Osteosarcopenia is more than sarcopenia and osteopenia alone

The frailty syndrome in general practitioner care

C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction

Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients

Residual effects of muscle strength and muscle power training and detraining on physical function in community-dwelling prefrail older adults: a randomized controlled trial

Prospective Validation of the Modified Mini Nutritional Assessment Short‐Forms in the Community, Nursing Home, and Rehabilitation Setting

Impact of age, performance and athletic event on injury rates in master athletics - first results from an ongoing prospective study.

The Fried Frailty Criteria as Inclusion Criteria for a Randomized Controlled Trial: Personal Experience and Literature Review